
Robert W. Downs
Examiner (ID: 17152)
| Most Active Art Unit | 2308 |
| Art Unit(s) | 2762, 4762, 2309, 2308, 2165 |
| Total Applications | 581 |
| Issued Applications | 448 |
| Pending Applications | 24 |
| Abandoned Applications | 109 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15663821
[patent_doc_number] => 10596116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
[patent_app_type] => utility
[patent_app_number] => 15/613847
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 59
[patent_no_of_words] => 23709
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613847
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/613847 | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders | Jun 4, 2017 | Issued |
Array
(
[id] => 12091348
[patent_doc_number] => 20170348442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 15/611577
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 41439
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611577
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611577 | COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS | May 31, 2017 | Abandoned |
Array
(
[id] => 14464805
[patent_doc_number] => 20190184042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/305284
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305284
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/305284 | PET imaging with PD-L1 binding polypeptides | May 30, 2017 | Issued |
Array
(
[id] => 12637596
[patent_doc_number] => 20180104362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => PRE-AND-INTRA-OPERATIVE LOCALIZATION OF PENILE SENTINEL NODES
[patent_app_type] => utility
[patent_app_number] => 15/610102
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15610102
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/610102 | Pre-and-intra-operative localization of penile sentinel nodes | May 30, 2017 | Issued |
Array
(
[id] => 12238548
[patent_doc_number] => 20180071411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/602141
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8102
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/602141 | STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID | May 22, 2017 | Abandoned |
Array
(
[id] => 12052542
[patent_doc_number] => 20170328886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'SYSTEMS AND METHODS FOR DETERMINING THERAPEUTIC UPTAKE AND DOSING'
[patent_app_type] => utility
[patent_app_number] => 15/594131
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11252
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15594131
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/594131 | SYSTEMS AND METHODS FOR DETERMINING THERAPEUTIC UPTAKE AND DOSING | May 11, 2017 | Abandoned |
Array
(
[id] => 14102365
[patent_doc_number] => 20190092858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => CD31SHED AS A MOLECULAR TARGET FOR IMAGING OF INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/098488
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098488 | CD31 | May 2, 2017 | Issued |
Array
(
[id] => 12000130
[patent_doc_number] => 20170304284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging'
[patent_app_type] => utility
[patent_app_number] => 15/495971
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 198
[patent_figures_cnt] => 198
[patent_no_of_words] => 20204
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15495971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/495971 | Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging | Apr 23, 2017 | Issued |
Array
(
[id] => 16981310
[patent_doc_number] => 20210225547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => HIGH SPECIFIC ACTIVITY PREPARATION OF F-18 TETRAFLUOROBORATE
[patent_app_type] => utility
[patent_app_number] => 16/095865
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095865 | High specific activity preparation of F-18 tetrafluoroborate | Apr 23, 2017 | Issued |
Array
(
[id] => 13137569
[patent_doc_number] => 10086096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Triazine based radiopharmaceuticals and radioimaging agents
[patent_app_type] => utility
[patent_app_number] => 15/492933
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16799
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492933 | Triazine based radiopharmaceuticals and radioimaging agents | Apr 19, 2017 | Issued |
Array
(
[id] => 19338561
[patent_doc_number] => 12048732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Methods of treating breast cancer
[patent_app_type] => utility
[patent_app_number] => 16/093508
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 46
[patent_no_of_words] => 45739
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093508 | Methods of treating breast cancer | Apr 13, 2017 | Issued |
Array
(
[id] => 12023959
[patent_doc_number] => 20170314056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'METHOD OF USING NEAR INFRARED FLUORESCENT DYES FOR IMAGING AND TARGETING CANCERS'
[patent_app_type] => utility
[patent_app_number] => 15/487320
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 30717
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487320
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487320 | METHOD OF USING NEAR INFRARED FLUORESCENT DYES FOR IMAGING AND TARGETING CANCERS | Apr 12, 2017 | Abandoned |
Array
(
[id] => 11756045
[patent_doc_number] => 20170202912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA'
[patent_app_type] => utility
[patent_app_number] => 15/471992
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 27724
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471992
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471992 | OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA | Mar 27, 2017 | Abandoned |
Array
(
[id] => 11962131
[patent_doc_number] => 20170266285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED HEMOGLOBIN-BASED THERAPEUTIC AGENT FOR CANCER TARGETING TREATMENT AND DIAGNOSTIC IMAGING'
[patent_app_type] => utility
[patent_app_number] => 15/469978
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 10299
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469978
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469978 | Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging | Mar 26, 2017 | Issued |
Array
(
[id] => 17434830
[patent_doc_number] => 11260136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Radio-pharmaceutical complexes
[patent_app_type] => utility
[patent_app_number] => 16/087040
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13079
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087040
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087040 | Radio-pharmaceutical complexes | Mar 19, 2017 | Issued |
Array
(
[id] => 11713692
[patent_doc_number] => 20170182192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'METHOD OF DRY DYE DELIVERY FOR STAINING THE EYE'
[patent_app_type] => utility
[patent_app_number] => 15/459078
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2057
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15459078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/459078 | METHOD OF DRY DYE DELIVERY FOR STAINING THE EYE | Mar 14, 2017 | Abandoned |
Array
(
[id] => 14043545
[patent_doc_number] => 20190077879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => CONJUGATES ENHANCING TOTAL CELLULAR ACCUMULATION
[patent_app_type] => utility
[patent_app_number] => 16/085141
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085141
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085141 | Conjugates enhancing total cellular accumulation | Mar 14, 2017 | Issued |
Array
(
[id] => 13955597
[patent_doc_number] => 20190054142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA
[patent_app_type] => utility
[patent_app_number] => 16/079787
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079787 | ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA | Feb 23, 2017 | Abandoned |
Array
(
[id] => 13955699
[patent_doc_number] => 20190054193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => ACTIVITY BASED PROBE AND USES THEREOF FOR IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/077879
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077879 | Activity based probe and uses thereof for imaging | Feb 15, 2017 | Issued |
Array
(
[id] => 12000316
[patent_doc_number] => 20170304471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'ANTICANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/427355
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14484
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427355
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427355 | Anticancer therapy | Feb 7, 2017 | Issued |